Aerie Pharmaceuticals Appoints Peter Lang as Chief Financial Officer | Business Wire
Rx Item-RHOPRESSA 0.02 % O/S 2.5 ML netarsudil mesylate DROPS BY AERIE PHARMA
Aerie Pharmaceuticals to Merge with Global Eye-Care Company Alcon | North Carolina Biotechnology Center
Aerie Pharmaceuticals Reports Third Quarter 2022 Financial Results | Business Wire
Aerie Pharma rockets on news of takeover bid
Aerie Pharmaceuticals (AERI) Stock | Helping Treatment with Glaucoma - Warrior Trading News
Aerie Pharma slips after announcing eye disease trial failed to meet primary endpoints | Seeking Alpha
AeriePharma (@AeriePharma) / X
Aerie Pharmaceuticals Inc. Company Profile - The Business Journals
Aerie Pharma (AERI) Falls on Glaucoma Eye Drop Safety Concerns - TheStreet
AERIE PHARMACEUTICALS, INC. NPS 2022
Aerie Pharmaceuticals and GrayBug Announce Research Collaboration | Business Wire
Aerie Pharma Dips On 'Minor' Glaucoma Setback And Q3 Miss | Stock News & Stock Market Analysis - IBD
Alcon to Acquire Aerie Pharmaceuticals, Inc., Enhancing its Ophthalmic Pharmaceutical Portfolio
Aerie to build manufacturing facility in Ireland
Alcon ups its glaucoma game again with $770M Aerie Pharma acquisition - MedCity News
Durham-based Aerie Pharma is sold to global eye care giant in deal worth $770M - Research Triangle Regional Partnership
Aerie Pharmaceuticals | LinkedIn
Aerie Pharmaceuticals Announces Agreement to Acquire Avizorex Pharma to Advance Its Dry Eye Program | World Pharma Today
Aerie Pharmaceuticals Inc (AERI) - Financial and Strategic SWOT Analysis Review
Rx Item-Rocklatan 0.02% 2.5 ML O/S-Keep Refrigerated - by Ae
Aerie Pharmaceuticals - Crunchbase Company Profile & Funding
Aerie Pharma appoints Richard Rubino as CFO | Healthcare Digital
AERIE PHARMACEUTICALS, INC. 2022 NPS
Aerie Pharmaceuticals, Inc. — Duke OTC
Aerie Pharma Seeks FDA Nod to Sell Ireland-based Product in US | INN
